Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Clinical Study Results

  • BI 1034020 - Healthy
    Clinical Study Number 1312.1
    Study Indication Healthy
    Product BI 1034020
    Generic Name BI 1034020
    Lab Code
    Clinical Phase I
    Study Title

    Safety, tolerability, pharmacokinetics and pharmacodynamics of single rising intravenous and subcutaneous doses of BI 1034020 in healthy male volunteers (partially randomised, single-blind, placebo-controlled within dose groups, clinical phase I study)

    Study Document
    Trial statement 1312.1_DR english
    Trial synopsis 1312.1_DR english